Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PRAD | rs112720640 | chr1:167512477 | C/T | 0.00013 | 494 | 30.93 | 30.9 | 15.77 | KM Plot |
PRAD | rs112733189 | chr1:1159729 | T/G | 2.58E-10 | 487 | 31.27 | 30.73 | 13.73 | KM Plot |
PRAD | rs112793476 | chr4:187812111 | A/C | 2.06E-6 | 483 | 31.13 | 28.57 | 26.8 | KM Plot |
PRAD | rs112794807 | chr4:165646631 | GCAGGCTGGACAA/G | 5.68E-5 | 492 | 30.77 | 32.9 | 44.32 | KM Plot |
PRAD | rs112816977 | chr3:184190620 | C/T | 0.000172 | 475 | 32.27 | 28.23 | 30.02 | KM Plot |
PRAD | rs112819899 | chr5:154231179 | T/C | 8.33E-9 | 493 | 30.23 | 33.27 | 20.47 | KM Plot |
PRAD | rs112892500 | chr16:22247276 | G/A | 3.44E-9 | 479 | 30.3 | 35.13 | 28.25 | KM Plot |
PRAD | rs112913435 | chr4:187812462 | G/A | 2.34E-6 | 480 | 31.13 | 28.43 | 26.8 | KM Plot |
PRAD | rs1129212 | chr16:87731878 | A/G | 1.04E-6 | 494 | 26.1 | 30.98 | 30.93 | KM Plot |
PRAD | rs112957687 | chr12:10735006 | C/A | 4.81E-5 | 488 | 30.8 | 33.13 | 19.93 | KM Plot |
PRAD | rs11311569 | chr21:36959520 | TA/T | 2.28E-5 | 487 | 30.5 | 30.2 | 31.18 | KM Plot |
PRAD | rs113206229 | chr12:10724532 | C/T | 5.74E-5 | 488 | 30.8 | 32.77 | 19.93 | KM Plot |
PRAD | rs113206287 | chr1:1159020 | A/G | 2.84E-10 | 485 | 31.27 | 30.73 | 13.73 | KM Plot |
PRAD | rs113220577 | chr19:49983010 | G/A | 7.14E-7 | 479 | 30.3 | 33.13 | 24.25 | KM Plot |
PRAD | rs113226566 | chr17:37810439 | A/G | 5.91E-6 | 489 | 30.87 | 32.45 | 28.63 | KM Plot |